SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001783937-23-000001
Filing Date
2023-10-10
Accepted
2023-10-10 11:04:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2949
  Complete submission text file 0001783937-23-000001.txt   4755
Mailing Address 55TH-56TH FLOOR, NEW BUND CENTER 555 WEST HAIYANG ROAD, PUDONG DISTRICT SHANGHAI F4 200124
Business Address 55TH-56TH FLOOR, NEW BUND CENTER 555 WEST HAIYANG ROAD, PUDONG DISTRICT SHANGHAI F4 200124 862160578000
I-Mab (Subject) CIK: 0001778016 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39173 | Film No.: 231316553
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 6601-6606, PLAZA 66, TOWER 1 1266 WEST NANJING ROAD SHANGHAI F4 200040
Business Address SUITE 6601-6606, PLAZA 66, TOWER 1 1266 WEST NANJING ROAD SHANGHAI F4 200040 862180125755
Everest Medicines Ltd (Reporting) CIK: 0001783937 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144
SIC: 2834 Pharmaceutical Preparations